Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Emmanuel Rautou

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
Circulation Research|December 18, 2010
Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migrationPierre-Emmanuel Rautou, Aurélie S Leroyer, Bhama Ramkhelawon, et al.
Physics in Medicine and Biology|October 27, 2018
Ultrasonic fat fraction quantification using in vivo adaptive sound speed estimationMarion Imbault, Marco Dioguardi Burgio, Alex Faccinetto, et al.
European Radiology|June 25, 2025
Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation studyMacil Hamadouche, Valérie Vilgrain, Christian Hobeika, et al.
Hepatology (Baltimore, Md.)|October 7, 2014
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal studyFilipe Nery, Sylvie Chevret, Bertrand Condat, et al.
Journal of Hepatology|September 2, 2015
Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injuryPierre-Emmanuel Rautou, Kohei Tatsumi, Silvio Antoniak, et al.
Chest|October 8, 2018
Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary SyndromeClément Lejealle, Valérie Paradis, Onorina Bruno, et al.
Journal of Hepatology|October 18, 2019
Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantationValerio Giannelli, Olivier Roux, Cédric Laouénan, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2019
Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal studyFilipe Nery, Sofia Correia, Carlos Macedo, et al.
Hepatology (Baltimore, Md.)|May 21, 2014
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis CLaure Elkrief, Pascale Chouinard, Noelle Bendersky, et al.
European Journal of Gastroenterology & Hepatology|November 19, 2020
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal studyFilipe Nery, Paula Carneiro, Sofia Correia, et al.
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Circulation Research|December 18, 2010
Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migrationPierre-Emmanuel Rautou, Aurélie S Leroyer, Bhama Ramkhelawon, et al.
Physics in Medicine and Biology|October 27, 2018
Ultrasonic fat fraction quantification using in vivo adaptive sound speed estimationMarion Imbault, Marco Dioguardi Burgio, Alex Faccinetto, et al.
European Radiology|June 25, 2025
Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation studyMacil Hamadouche, Valérie Vilgrain, Christian Hobeika, et al.
Hepatology (Baltimore, Md.)|October 7, 2014
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal studyFilipe Nery, Sylvie Chevret, Bertrand Condat, et al.
Journal of Hepatology|September 2, 2015
Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injuryPierre-Emmanuel Rautou, Kohei Tatsumi, Silvio Antoniak, et al.
Chest|October 8, 2018
Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary SyndromeClément Lejealle, Valérie Paradis, Onorina Bruno, et al.
Journal of Hepatology|October 18, 2019
Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantationValerio Giannelli, Olivier Roux, Cédric Laouénan, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2019
Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal studyFilipe Nery, Sofia Correia, Carlos Macedo, et al.
Hepatology (Baltimore, Md.)|May 21, 2014
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis CLaure Elkrief, Pascale Chouinard, Noelle Bendersky, et al.
European Journal of Gastroenterology & Hepatology|November 19, 2020
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal studyFilipe Nery, Paula Carneiro, Sofia Correia, et al.
Pageof 20